2024-10-19 04:31:41
I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Multiple Cancer Types
Health/ 2023-07-22
I-Mab Biopharma Announces Clinical Colla...

SHANGHAI,Sept. 23,2019-- I-Mab Biopharma ("I-Mab"),a China and U.S.-based clinical stage biopharmaceutical company exclusively foc...

PolyU develops a new class of antibiotic candidates for fighting against superbugs
Health/ 2023-07-22
PolyU develops a new class of antibiotic...

HONG KONG,Sept. 24,2019-- The Hong Kong Polytechnic University (PolyU) has developed a new class of antibiotic drug candidates which has hig...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release